1. Home
  2. ESQ vs PHAR Comparison

ESQ vs PHAR Comparison

Compare ESQ & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESQ
  • PHAR
  • Stock Information
  • Founded
  • ESQ 2006
  • PHAR 1988
  • Country
  • ESQ United States
  • PHAR Netherlands
  • Employees
  • ESQ N/A
  • PHAR N/A
  • Industry
  • ESQ Commercial Banks
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESQ Finance
  • PHAR Health Care
  • Exchange
  • ESQ Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • ESQ 838.1M
  • PHAR 1.0B
  • IPO Year
  • ESQ 2017
  • PHAR N/A
  • Fundamental
  • Price
  • ESQ $99.35
  • PHAR $14.27
  • Analyst Decision
  • ESQ Hold
  • PHAR Strong Buy
  • Analyst Count
  • ESQ 3
  • PHAR 3
  • Target Price
  • ESQ $103.00
  • PHAR $30.00
  • AVG Volume (30 Days)
  • ESQ 52.9K
  • PHAR 12.8K
  • Earning Date
  • ESQ 10-23-2025
  • PHAR 10-23-2025
  • Dividend Yield
  • ESQ 0.71%
  • PHAR N/A
  • EPS Growth
  • ESQ 12.45
  • PHAR N/A
  • EPS
  • ESQ 5.39
  • PHAR N/A
  • Revenue
  • ESQ $126,841,000.00
  • PHAR $339,836,000.00
  • Revenue This Year
  • ESQ N/A
  • PHAR $16.63
  • Revenue Next Year
  • ESQ $10.14
  • PHAR $6.77
  • P/E Ratio
  • ESQ $18.41
  • PHAR N/A
  • Revenue Growth
  • ESQ 12.91
  • PHAR 22.44
  • 52 Week Low
  • ESQ $60.42
  • PHAR $7.31
  • 52 Week High
  • ESQ $106.11
  • PHAR $17.08
  • Technical
  • Relative Strength Index (RSI)
  • ESQ 53.98
  • PHAR 54.65
  • Support Level
  • ESQ $92.33
  • PHAR $13.63
  • Resistance Level
  • ESQ $98.73
  • PHAR $14.97
  • Average True Range (ATR)
  • ESQ 1.86
  • PHAR 0.86
  • MACD
  • ESQ -5.19
  • PHAR -0.13
  • Stochastic Oscillator
  • ESQ 98.49
  • PHAR 35.98

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: